Detailed answers about CRUZE PHARMA MEDICAL COMPANY LTD, including incorporation, status, business activity, and accounts information.
When was CRUZE PHARMA MEDICAL COMPANY LTD founded?
CRUZE PHARMA MEDICAL COMPANY LTD was officially incorporated on 24 September 2025 and is registered under company number 16740604. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CRUZE PHARMA MEDICAL COMPANY LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CRUZE PHARMA MEDICAL COMPANY LTD?
CRUZE PHARMA MEDICAL COMPANY LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CRUZE PHARMA MEDICAL COMPANY LTD do?
CRUZE PHARMA MEDICAL COMPANY LTD operates in the following sectors: 21200 - Manufacture of pharmaceutical preparations, 46450 - Wholesale of perfume and cosmetics, 46460 - Wholesale of pharmaceutical goods, 46900 - Non-specialised wholesale trade. These SIC codes provide insight into the company's business activities and industry focus.
What is CRUZE PHARMA MEDICAL COMPANY LTD's registered address?
The registered office address of CRUZE PHARMA MEDICAL COMPANY LTD is UNIT 7 INITIAL BUSINESS CENTRE, WILSON BUSINESS PARK, MANCHESTER, ENGLAND, M40 8WN. This is the official address filed with Companies House for legal and statutory correspondence.
Is CRUZE PHARMA MEDICAL COMPANY LTD financially stable?
Financial accounts for CRUZE PHARMA MEDICAL COMPANY LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.